Merck & Co., Inc. MRK
At closeNov 13, 2026, 4:02 PM EST
After hours · Nov 13, 4:02 PM ET
- YTD
- +40.38%
- 1 year
- +59.00%
Discussion (164)
Sign in to join the discussion
frank fager MRK 1 year ago #21Michael why? Keytruda is going off patent in a few years and ImmunityBio with Anktiva and BioShield will destroy Keytruda sales!
2024 35 billion 2026 10 billion max
frank fager MRK 1 year ago #22
ImmunityBio https://immunitybio.com/ told me they were doing trial analysis for glioblastoma about 3 weeks ago. I knew it was positive. This is huge because trials going to first line treatment, when people aren’t beaten down with radiation and chemo poisons are going to really shine! Multiple FDAs soon and right to try off label! Keytruda is used for 18 cancer and Anktiva and BioShield are kicking its ass when all else has failed including Keytruda!
frank fager MRK 1 year ago #23J&J Moderna and PFE should pay billions in damages for the jabs. They hid the risks as they were directed to by the FDA CDC NIH WHO to rush it to market! So glad I knew it was poison! It with Covid may be causing all the cancer.
frank fager MRK 1 year ago #24TheFLY
I agree why should your employer limit your option to their chosen picks that are usual their rich buds investment company!
frank fager MRK 1 year ago #25No way ImmunityBio IBRX gets taken over ever EVER by an evil greedy Big Pharma company that never ever cures anything. They only treat and cause side effects and in the end kill people! Merck MRK is a greedy evil Big Pharma..... So sell MRK and buy IBRX
Keytruda is finished now, Big Pharma no longer controls the FDA and the other 3 letter agencies! It's over! Keytruda can cause death by turning your immune system loose to attack your self gee an autoimmune induced death, WONDERFUL side effect!
frank fager MRK 1 year ago #26"In the United States, Merck & Co., Inc. is the sole manufacturer and supplier of TICE BCG, a strain used in bladder cancer treatment. While Merck has significantly increased its production, global demand still outpaces supply, leading to a shortage"
So what does Dr.PSS. do so Merck won't control Anktiva's use? Goes to India to bypass Merck or Merck would have been in control of Anktiva via BCG. . “Our collaboration with the FDA and Serum Institute to ensure a reliable supply of this vital drug for bladder cancer patients underscores ImmunityBio’s commitment to addressing critical access issues that affect so many patients.”
frank fager MRK 1 year ago #27MRK Keytruda no thank you it had cured CURED zero patients!!!!! I would rather treat my cancer with
Ivermectin
Methylene blue
Fenbendazole
At least they don't trigger an autoimmune attack of heathy cells that can lead to death!
Best treatment would be those 3 plus Anktiva from ImmunityBio, IBRX
frank fager MRK 1 year ago #28Let's look at CR numbers for Keytruda vs Anktiva from Al.
KEYTRUDA: CR rate of Keytruda is between 27% to 30% for relapsed or refractory classical Hodgkin lymphoma. In early-stage breast cancer, the CR rate was at 24.3% with chemotherapy.
ANKTIVA: CR rate of ANKTIVA is approximately 62% to 71% for blader cancer. This means that a significant portion of patients showed no evidence of cancer after treatment.
See, Keytruda falls far behind Anktiva in immunotherapy. That says Anktiva is the one and only immunotherapy.
During the trials, company(s) will know somehow the results in real time. AND with combo trial, CR rate will jump with cancer curing efficacy of Anktiva. This is a strategic move by Merck on how good Anktiva is and come up with a price tag for Anktiva.
Then, Merck has to decide how to maintain its $30BILLION annual sales which will lose its patent protection soon. You got the answer: buy Anktiva out or what, partnership?
frank fager MRK 1 year ago #29Sell MRK and buy IBRX
frank fager MRK 1 year ago #30How many of you have seen the Keytruda ad they say approval for 18 cancers but it can cause your immune system to attack health cells and could be fatal!
Doesn't Anktiva work when Keytruda is failing? Yes. Who makes Anktiva?
ImmunityBio. So when we start getting multiple FDAs for Anktiva and then they say it can be used of label, full right to try, Keytruda is finished!
What was Keytruda's sales 2024 35 billion!